ArticleBMC microbiology2026
Multidrug resistance, biofilm formation, and pathotype diversity of Escherichia coli isolated from diarrheic lambs in intensive sheep farms, Aksu, Xinjiang, China.
Article in BMC microbiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Modulation of the gut microbiota by traditional Chinese medicine to attenuate chemotherapy-induced toxicity in gastric cancer: a review.Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
18 authors.
Funding
Abstract
backgroundUnder the One Health framework, the antimicrobial resistance and pathogenicity of Escherichia coli isolated from diarrheic lambs pose a potential threat to public health security. Aksu in Xinjiang is a major intensive mutton sheep breeding base in China. This study aimed to investigate the antimicrobial resistance, virulence gene carriage, biofilm-forming ability, pathotype distribution and phylogenetic group characteristics of E. coli from diarrheic lambs in this region, and analyze their potential correlations.
methodsA total of 150 samples were collected from diarrheic lambs in 6 intensive mutton sheep farms. E. coli was isolated and identified via differential media and specific gene detection; the disk diffusion method was used for antimicrobial susceptibility testing. PCR was performed to detect resistance and virulence gene carriage, and E. coli pathotypes were determined based on molecular characteristics. Mouse challenge assay was adopted to evaluate bacterial pathogenicity, crystal violet staining to assess biofilm-forming ability, and PCR to conduct phylogenetic group typing.
resultsA total of 121 E. coli strains were isolated with an isolation rate of 80.7%, including 38.0% multidrug-resistant (MDR) strains and 49.6% pathogenic strains (5 single pathotypes and 7 hybrid pathotypes). Mouse models showed all tested pathogenic strains had pathogenicity. Phylogenetic group analysis showed that group B1 was the predominant phylogroup (76.0%). Moreover, 78.6% of the strains had biofilm-forming ability, and MDR strains exhibited significantly higher biofilm-forming ability than non-MDR strains. The isolated strains harbored abundant resistance and virulence genes, with 13 different types of resistance genes and 18 virulence genes with distinct functions detected in total.
conclusionsThis is the first systematic report on the diversity characteristics of pathogenic E. coli from diarrheic lambs in intensive sheep farms in Aksu, clarifying the phylogenetic and antimicrobial resistance characteristics of the strains and revealing a significant association between biofilm formation and bacterial resistance. These findings provide a basis for the coordinated management of cross-domain public health risks in underdeveloped regions under the One Health framework, and contribute to the sustainable development of the mutton sheep industry and the safeguard of public health security.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.